17.08
17.08 (0%)
As of Apr 17, 2025
IDEAYA Biosciences, Inc. [IDYA]
Source:
Company Overview
Ideaya Biosciences, Inc. is a precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics.
| Country | United States |
| Headquarters | south san francisco, california |
| Phone Number | 650-443-6209 |
| Industry | manufacturing |
| CEO | Yujiro Hata |
| Website | www.ideayabio.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $7 |
| Operating Profit | $-327 |
| Net Income | $-274.5 |
| Net Cash | $-72.6 |
Profit Ratios
| Gross Margin | $7 |
| Operating Margin | -4,671.1 |
| Profit as % of Revenues | -2.6% |
| Profit as % of Assets | -31% |
| Profit as % of Stockholder Equity | -25.9% |
Management Effectiveness
| Return on Equity | -25.9% |
| Return on Assets | -24.4% |
| Turnover Ratio | 0.8% |
| EBITA | $-327 |
Balance Sheet and Cash Flow Measures
| Total Assets | $1,124.1 |
| Total Liabilities | $64.9 |
| Operating Cash Flow | $-247.6 |
| Investing Cash Flow | $-502.6 |
| Financing Cash Flow | $677.6 |
